Benzinga's Top Upgrades
Compass Point upgraded First Horizon National (NYSE: FHN) from “sell” to “neutral.” First Horizon National's shares closed at $8.23 yesterday. First Horizon National had $2.70 billion in total cash for the latest quarter.
Roth Capital upgraded RTI Biologics (NASDAQ: RTIX) from “neutral” to “buy.” RTI Biologics's stock closed at $3.56 yesterday. RTI Biologics's PEG ratio is 1.00.
Analysts at Deutsche Bank upgraded Wal-Mart Stores (NYSE: WMT) from “sell” to “hold.” Wal-Mart's shares closed at $74.43 yesterday. Wal-Mart's trailing-twelve-month revenue ROE is 23.49%.
HSBC upgraded Aixtron SE (NASDAQ: AIXG) from “underweight” to “neutral.” Aixtron's shares closed at $13.15 yesterday. Aixtron's trailing-twelve-month revenue is $389.91 million.
Latest Ratings for FHN
|Jan 2017||JP Morgan||Upgrades||Neutral||Overweight|
|Dec 2016||Bank of America||Upgrades||Underperform||Neutral|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.